The present study sought to determine whether or not Positron Emission
Tomography (PET) with the newly developed positron emitting serotonin
(5-HT) transporter ligand, (+)[C-11]McN-5652, could be used to detect
fenfluramine-induced 5-HT neurotoxicity in the brain of living primat
es (baboons). Six PET imaging studies were performed: three before tre
atment with fenfluramine (5 mg/kg, s.c., twice daily for 4 days) and t
hree after (18, 45, and 81 days after treatment). The dose of fenflura
mine used in this study (5 mg/kg) is known to produce 5-HT neurotoxici
ty in primates, and to be approximately two times higher than a dose o
f fenfluramine reported to produce small and inconsistent weight loss
in baboons (2 mg/kg). Following fenfluramine treatment, marked lasting
reductions in regional brain specific binding of(+)[C-11]McN-5652 wer
e found by means of PET. Findings with PET corresponded well with post
-mortem neurochemical findings indicative of serotonergic neurotoxicit
y (lasting depletions of regional brain 5-HT, 5-HIAA, and 5-HT uptake
sites). These results suggest that PET imaging with (+)[C-11]McN-5652
will be useful for evaluating the 5-HT neurotoxic potential of fenflur
amine and related drugs in living humans. (C) 1996 Wiley-Liss, Inc.